SureTrader
Home > Boards > US Listed > Medical - Equipment >

Pressure BioSciences Inc. (PBIO)

PBIO RSS Feed
Add PBIO Price Alert      Hide Sticky   Hide Intro
Moderator: NetworkNewsWire
Search This Board: 
Last Post: 4/18/2018 11:34:37 AM - Followers: 28 - Board type: Free - Posts Today: 0

       
       
             

 

(PBIO)  Pressure BioSciences Inc.   

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.

                                                                               http://www.pressurebiosciences.com 

IDecember 2, 2016 - Pressure Biosciences featured on Barron's Financial Site: http://www.barrons.com/articles/PR-CO-20161202-907681
 

                                                     


 

             COMPANY NEWS
 


Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update (Nov 21, 2016)

Pressure BioSciences (PBIO) Achieves Record Revenue on Road to Profitability -- SECFilings.com
 (Nov 16, 2016)

Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update (Nov 21, 2016)

Pressure BioSciences Announces Initial Close of $610,000 in $2.5 Million Private Placement 
(Nov 14, 2016)
Pressure BioSciences (PBIO) Secures Funding Allowing for Accelerated Corporate Development -- SECFilings.com
 (Nov 04, 2016)
Pressure BioSciences, Inc. Closes $2,000,000 Line-of-Credit
 (Nov 03, 2016)
Pressure BioSciences' PCT Platform Featured at Official Launch of Major Cancer Research Center Recently Chosen as a Collaborator in the US "Cancer Moonshot" Initiative
October 26, 2016

Pressure BioSciences, Inc. to Present at the Fall SeeThruEquity Microcap Investment Conference in New York City
Oct. 17, 2016
SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO)

October 14, 2016 
Cancer Moonshot Should Benefit Pharma Companies, Investors
Sept, 6, 2016
Pressure BioSciences, Inc. Reports Second Quarter 2016 Financial Results and Provides Business Update

Aug. 16, 2016
StockWatchIndex Research Report
July 21, 2016
Pressure BioSciences Unveils Barocycler 2320EXT at Major Scientific Meeting; Next Generation PCT-based Instrument Expected to be Centerpiece of the Recently Announced Co-Marketing Agreement with Global Life Sciences Analytical Technologies Leader SCIEX

July 13, 2016

 
Videos   
   
 

CEO Interview: Richard Schumacher of (OTCQB: PBIO) w/ TheStreet.com Analyst John Persinos
Aug 25, 2016


Pressure BioSciences: Game-Changing Tech for $6B Life Sciences Sample Prep Market
Aug 3, 2016



 


Jane King Interviews the CEO of Pressure Biosciences, Inc. (OTCQB: PBIO) 
July 21, 2016


Pressure BioSciences (OTC:QB PBIO) CEO (Richard Schumacher - First Look EquitiesInvestor Summit. 
June 5, 2016



 



SNNLive Newscast with Pressure BioSciences, Inc. (OTCQB: PBIO)
June 2, 2016


Pressure BioSciences, Inc. (PBIO) CEO Richard Schumacher at the US HPO Conference on iTownHall
March 15, 2016
 


 
         

DISCLAIMER

Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their owndue diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.

SureTrader
PBIO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PBIO News: Annual Report (10-k) 04/02/2018 04:56:31 PM
PBIO News: Statement of Changes in Beneficial Ownership (4) 03/28/2018 05:02:56 PM
PBIO News: Statement of Changes in Beneficial Ownership (4) 03/28/2018 05:02:56 PM
PBIO News: Statement of Changes in Beneficial Ownership (4) 03/28/2018 05:02:56 PM
PBIO News: Statement of Changes in Beneficial Ownership (4) 03/28/2018 05:02:56 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#824   Enabling The Perfect Match & Delivery Technology-Process For the reaper 04/18/18 11:34:36 AM
#823   $PBIO Don't Forget Conference Call Tomorrow April 3rd-For the reaper 04/02/18 01:32:00 PM
#822   Why Not Buy #PBIO - Doors Open to the reaper 03/27/18 02:28:32 PM
#821   #PBIO - OPENS DOORS to the CBD's (Oils, the reaper 03/26/18 11:00:49 AM
#820   $PBIO Support Can Move this Over $5.00-Do Your Research the reaper 03/21/18 02:11:29 PM
#819   Pressure BioSciences, Inc. (OTCQB:PBIO)CEO Schumacher Outlines Why Continued the reaper 03/13/18 01:15:50 PM
#818   The Quiet Investor Issues March 2018 Publication Featuring the reaper 03/05/18 12:54:36 PM
#817   PBIO Enters Agreement to Create Unique Analytical System NetworkNewsWire 02/26/18 03:21:14 PM
#816   PBIO Technology Could Provide Ideal Drug Delivery of Cannabinoids NetworkNewsWire 02/22/18 03:36:18 PM
#815   PBIO Agreement with ISS, Inc. Shows Potential to NetworkNewsWire 02/21/18 02:04:31 PM
#814   PBIO Just Might Have the Ideal Drug Delivery NetworkNewsWire 02/15/18 01:00:14 PM
#813   PBIO Enters Co-Marketing, Distribution Agreement with ISS, Inc. NetworkNewsWire 02/14/18 11:17:36 AM
#812   #PBIO Pressure BioSciences, Inc. & ISS, Inc. Announce the reaper 02/14/18 11:01:43 AM
#811   PBIO Poised to Move - Very Thin Float the reaper 02/02/18 04:03:14 PM
#810   PBIO CEO Discusses Recent Corporate Milestones in Webinar Update NetworkNewsWire 02/02/18 03:47:19 PM
#809   $PBIO Different Company Than a Month Ago What's the reaper 01/24/18 10:53:31 AM
#808   #PBIO Opportunity Knocks - Record Sales Expected 2018 the reaper 01/02/18 03:41:02 PM
#807   PBIO Entry into Biopharmaceutical Industry Focus of Zacks NetworkNewsWire 12/28/17 12:49:38 PM
#806   Alert:Conference Call Today 4:30pm (ET) News Today> the reaper 12/20/17 01:50:56 PM
#805   PBIO Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument NetworkNewsWire 12/20/17 01:12:48 PM
#804   #PBIO Invites Everyone to their Conference Call Wed the reaper 12/19/17 01:36:01 PM
#803   Breaking News - $PBIO Pressure BioSciences, Inc. (PBI) the reaper 12/13/17 12:27:50 PM
#802   PBIO Acquires All Assets of BaroFold, Inc. NetworkNewsWire 12/13/17 11:36:29 AM
#801   PBIO Technology Helps Maintain Integrity of Lab Science NetworkNewsWire 12/08/17 01:52:56 PM
#800   PBIO Targets Nanoemulsions Market Through Collaboration with Phasex Corp. NetworkNewsWire 11/29/17 11:37:46 AM
#799   $PBIO Record Sales/Revenue-Continued Growth Expected-International Expansion the reaper 11/27/17 02:09:47 PM
#798   PBIO Forms Strategic Collaboration with Phasex Corporation to NetworkNewsWire 11/27/17 10:08:32 AM
#797   PBIO Q3 Top Line Marks Record Quarterly Growth NetworkNewsWire 11/22/17 10:19:38 AM
#796   November 21, 2017 the reaper 11/21/17 02:40:01 PM
#795   PBIO Achieves Record Quarterly Revenue Growth NetworkNewsWire 11/16/17 03:01:52 PM
#794   Looks like PBIO is back to issuing DEATH namtae 11/14/17 03:18:48 PM
#793   PBIO Posts Q3 2017 Financial Results, Provides Business Update NetworkNewsWire 11/14/17 02:48:56 PM
#792   PBIO to Host Teleconference Regarding Q3 2017 Financial Results NetworkNewsWire 11/13/17 11:48:41 AM
#791   PBIO Progresses in Global Life Sciences Industry NetworkNewsWire 11/08/17 12:43:56 PM
#790   PBIO Names First Center of Excellence in China, NetworkNewsWire 11/01/17 10:52:36 AM
#789   PBIO Game-Changing Pressure Cycling Technology Is Revolutionizing Scientific NetworkNewsWire 10/25/17 02:17:57 PM
#788   PBIO Management at a Glance NetworkNewsWire 10/20/17 01:52:17 PM
#787   PBIO Enters Collaboration Agreement with Phasex Corporation NetworkNewsWire 10/18/17 11:34:47 AM
#786   @namtae All I can say is thank you for mikeonmicrocaps 10/18/17 05:00:23 AM
#785   PBIO should cease with all the cheap sales namtae 10/16/17 10:12:21 AM
#784   PBIO is “One to Watch” NetworkNewsWire 10/16/17 10:06:56 AM
#783   CEO Richard T. Schumacher Discusses Pressure BioScience’s New ProfitScout 10/10/17 09:32:38 AM
#782   I didnt know the business plan provided for namtae 09/21/17 03:16:40 PM
#781   Richard business plan is what he said it Jmach101 09/21/17 02:39:57 PM
#780   Somethings not adding up namtae 09/21/17 08:06:43 AM
#779   Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalis ProfitScout 09/19/17 09:17:41 AM
#778   Pressure BioSciences, Inc. to Present at the 19th ProfitScout 09/11/17 01:26:36 PM
#777   stock price back up above $3, but the BugStocks_com 08/31/17 11:16:19 AM
#776   Appears complete lack of liquidity may be the namtae 08/31/17 10:21:55 AM
#775   Interesting market for PBIO this morning... I thought namtae 08/31/17 09:37:32 AM
PostSubject